Global Consortium for Biomarker Standardization
At a Glance
- Status: Active Consortium
- Year Launched: 2010
- Initiating Organization: Alzheimer's Association
- Initiator Type: Nonprofit foundation
- Disease focus:
- Location: North America
The Alzheimer’s Association has established the Global Consortium for Biomarker Standardization to gather key researchers, clinicians, and industry, regulatory, and government leaders in Alzheimer’s disease (AD) to achieve consensus on the best ways to standardize and validate biomarker tests for use in clinical practices around the world.
The Consortium will continue to grow and expand as the field identifies novel technologies and techniques for diagnosis of AD. To date, projects are addressing the following:
July 7, 2011: Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, et al. Alzheimer’s & Dementia. The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers.
Points of Contact
Maria C. Carrillo, Ph.D.
Vice President, Medical & Scientific Relations
Sponsors & Partners